Development of the Pediatric Weight Questionnaire (PWQ™) for Children and Adolescents with Obesity.

ABSTRACT:

Introduction

Development of obesity management medications (OMMs) for use in children and adolescents calls for patient-reported outcome (PRO) measures to evaluate treatment efficacy. Existing weight-specific symptom and impact PROs are limited to age ≥ 11 years and may not fully capture treatment benefit of new OMMs.

Methods

A targeted literature review was conducted to identify obesity symptom and impact outcomes and weight-specific PROs relevant to children and adolescents 6-17 years of age. Concept elicitation (CE) interviews were conducted by telephone with children and adolescents, including parents of children 6-11 years of age, to identify relevant weight-specific concepts. Key concepts relevant to three developmental age groups-6-7, 8-11, and 12-17 years-informed th

SUBMITTER: Boye KS 

PROVIDER: S-EPMC12394325 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature